Physician profile
Ted Olin Morgan
NPI 1639160245
$3,464.81
in general payments reported to CMS, 2019-2025
16 companies · $1,973 in 2025
The $1,973 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.03 · 2020: $21.74 · 2021: $282 · 2022: $774 · 2023: $178 · 2024: $155 · 2025: $1,973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,217 · Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,217.05 |
| Food and Beverage | $1,088.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $1,746.07 | 2025 | Illuccix |
| Procept Biorobotics Corporation | $709.36 | 2022-2024 | Aquabeam System |
| Pfizer INC. | $200.18 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $136.84 | 2022-2025 | |
| Inspire Medical Systems, INC. | $135.72 | 2021 | |
| Myriad Genetic Laboratories, INC. | $105.40 | 2022-2025 | Prolaris |
| Myovant Sciences INC. | $97.24 | 2021-2022 | |
| Boston Scientific Corporation | $82.03 | 2019 | |
| Amgen INC. | $50.74 | 2020-2023 | Prolia |
| Coloplast Corp | $49.66 | 2021-2023 | Altis |
| Ferring Pharmaceuticals INC. | $35.15 | 2024-2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $31.91 | 2025 | |
| Abbvie INC. | $27.30 | 2021 | |
| Mckesson Medical-Surgical, INC. | $20.00 | 2021 | |
| Astellas Pharma US INC | $19.32 | 2023 | Xtandi |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $17.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.